MYOSITIS
Clinical trials for MYOSITIS explained in plain language.
Never miss a new study
Get alerted when new MYOSITIS trials appear
Sign up with your email to follow new studies for MYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for rare Muscle-Weakening diseases
Disease control Recruiting nowThis study tests a new medicine called dazukibart (PF-06823859) for people with active dermatomyositis or polymyositis, rare diseases that cause muscle inflammation, weakness, and sometimes skin rash. About 318 adults will receive either the drug or a placebo as an IV infusion ev…
Matched conditions: MYOSITIS
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Engineered cells take aim at tough autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new treatment called CTX112 for people with severe autoimmune diseases like lupus, scleroderma, or myositis that haven't improved with standard therapies. CTX112 uses specially engineered immune cells from a donor to target and attack faulty immune …
Matched conditions: MYOSITIS
Phase: PHASE1 • Sponsor: CRISPR Therapeutics • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Immune cell combo tackles tough autoimmune conditions
Disease control Recruiting nowThis study tests a new treatment for people with certain autoimmune diseases (rheumatoid arthritis, Sjögren's disease, myositis, and scleroderma) that have not responded to standard therapies. The treatment combines AlloNK, a type of immune cell from donated cord blood, with ritu…
Matched conditions: MYOSITIS
Phase: PHASE2 • Sponsor: Artiva Biotherapeutics, Inc. • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
New handheld scanner could replace MRI for muscle disease monitoring
Diagnosis Recruiting nowThis study is testing a device called the mScan that uses a tiny, painless electrical current to measure muscle health in about 6 seconds. Researchers want to see if it can give similar information as an MRI, but faster and more conveniently. The study involves 150 adults with an…
Matched conditions: MYOSITIS
Sponsor: Beth Israel Deaconess Medical Center • Aim: Diagnosis
Last updated May 07, 2026 18:43 UTC
-
Could your environment trigger a rare muscle disease?
Knowledge-focused Recruiting nowThis study looks at whether certain environmental exposures—like infections, stress, or sun exposure—are more common in people with anti-synthetase syndrome (a type of myositis with lung involvement) compared to other myositis patients and healthy volunteers. Researchers will col…
Matched conditions: MYOSITIS
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC
-
Patients take the lead: rare disease research gets a new voice
Knowledge-focused Recruiting nowThis study asks people living with rare myositis diseases (and their caregivers) what research questions matter most to them. Researchers will collect ideas through online surveys and forums. The goal is to create a patient-driven list of priorities to guide future studies and fu…
Matched conditions: MYOSITIS
Sponsor: Myositis International Health & Research Collaborative Alliance Foundation • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC
-
Massive biobank launched to unlock mysteries of autoimmune illness
Knowledge-focused Recruiting nowThis study aims to create a large collection of blood and tissue samples from people with autoimmune diseases like lupus and scleroderma. Researchers will use these samples to learn more about how these diseases work, identify markers for diagnosis, and discover clues for future …
Matched conditions: MYOSITIS
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Apr 20, 2026 16:14 UTC